| RS2110954936 |
NAA15
|
Health Risk |
Likely pathogenic |
— |
| RS2110955293 |
NAA15
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2110956953 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2110957137 |
NAA15
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2110959790 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2110960030 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2110977229 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2110977312 |
NAA15
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2110977610 |
NAA15
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2111007067 |
NEK1
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2111009771 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2111013260 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS2111013273 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS2111013293 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2111015862 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS2111015936 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS2111021475 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS2111021738 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS2111022003 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS2111031951 |
LRAT
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2111032416 |
LRAT
|
Health Risk |
Pathogenic |
Abnormality of the eye, Leber congenital amaurosis 14 |
| RS2111032650 |
NEK1
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2111032788 |
LRAT
|
Health Risk |
Pathogenic |
— |
| RS2111038250 |
LRAT
|
Health Risk |
Likely pathogenic |
— |
| RS2111065159 |
TRAPPC11
|
Health Risk |
Likely pathogenic |
— |
| RS2111067026 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS2111067418 |
RAB33B
|
Health Risk |
Pathogenic |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS2111067546 |
LOC129993110;RAB33B
|
Health Risk |
Pathogenic |
— |
| RS2111067574 |
LOC129993110;RAB33B
|
Health Risk |
Pathogenic |
— |
| RS2111068100 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS2111068286 |
TRAPPC11
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS2111087458 |
RAB33B
|
Health Risk |
Pathogenic |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS2111234 |
NOD2
|
Health Risk |
Uncertain risk allele |
Leprosy, susceptibility to |
| RS2111335168 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2111348673 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS2111348918 |
TRAPPC11
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS2111354717 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2111362314 |
NDUFS6
|
Health Risk |
Likely pathogenic |
— |
| RS2111363477 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS2111364865 |
NDUFS6
|
Health Risk |
Likely pathogenic |
— |
| RS2111364901 |
NDUFS6
|
Health Risk |
Pathogenic |
— |
| RS2111571890 |
C7
|
Health Risk |
Likely pathogenic |
— |
| RS2111579916 |
C7
|
Health Risk |
Pathogenic |
— |
| RS2111585708 |
IL6ST
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 4A, autosomal dominant |
| RS2111585826 |
IL6ST
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 4A, autosomal dominant |
| RS2111587824 |
IL6ST
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 4A, autosomal dominant |
| RS2111600452 |
C7
|
Health Risk |
Pathogenic |
— |
| RS2111637536 |
C7
|
Health Risk |
Pathogenic |
— |
| RS2111677373 |
IL6ST
|
Health Risk |
Pathogenic |
Stuve-Wiedemann syndrome 2, Stuve-Wiedemann syndrome 2 |
| RS2111702150 |
MCIDAS
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2111713642 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia 29 |
| RS2111731768 |
C7
|
Health Risk |
Pathogenic |
— |
| RS2111774223 |
IL6ST
|
Health Risk |
Pathogenic |
Immunodeficiency 94 with autoinflammation and dysmorphic facies, Immunodeficiency 94 with autoinflammation and dysmorphic facies |
| RS2111818610 |
GHR
|
Health Risk |
Pathogenic |
— |
| RS2111832452 |
GHR
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2111835976 |
C9
|
Health Risk |
Pathogenic |
Complement component 9 deficiency, Complement component 9 deficiency |
| RS2111836553 |
C9
|
Health Risk |
Pathogenic |
— |
| RS2111839421 |
HCN1
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS2111840582 |
NPR3
|
Health Risk |
Pathogenic |
Boudin-Mortier syndrome, Boudin-Mortier syndrome |
| RS2111857806 |
LMBRD2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2111857835 |
LMBRD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with variable neurologic and brain abnormalities, Neurodevelopmental disorder |
| RS2111876683 |
C9
|
Health Risk |
Pathogenic |
— |
| RS2111887398 |
C9
|
Health Risk |
Pathogenic |
— |
| RS2111893851 |
MAP1B
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 9, Periventricular nodular heterotopia 9 |
| RS2111894733 |
MAP1B
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 9, Periventricular nodular heterotopia 9 |
| RS2111894757 |
MAP1B
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 9, Periventricular nodular heterotopia 9 |
| RS2111907902 |
LMBRD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with variable neurologic and brain abnormalities, LMBRD2-related disorder |
| RS2111911679 |
LMBRD2
|
Health Risk |
Likely pathogenic |
Developmental delay with variable neurologic and brain abnormalities, Developmental delay with variable neurologic and brain abnormalities |
| RS2111935997 |
NNT
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency 4, Glucocorticoid deficiency 4 |
| RS2111939767 |
FGF10
|
Health Risk |
Pathogenic |
— |
| RS2111960756 |
KIF2A
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2111962512 |
SLC45A2
|
Health Risk |
Pathogenic |
— |
| RS2112007724 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112007877 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112007970 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112007993 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS2112020238 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112020385 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112024354 |
DNAJC21
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 3, Bone marrow failure syndrome 3 |
| RS2112026621 |
MSH3
|
Health Risk |
Likely pathogenic |
— |
| RS2112026672 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112026812 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Endometrial carcinoma |
| RS2112026860 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112026895 |
MSH3
|
Health Risk |
Likely pathogenic |
— |
| RS2112031854 |
HCN1
|
Health Risk |
Pathogenic |
Febrile seizure (within the age range of 3 months to 6 years), Seizure |
| RS2112032137 |
HCN1
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS2112039335 |
DNAJC21
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 3, Bone marrow failure syndrome 3 |
| RS2112040618 |
HCN1
|
Health Risk |
Likely pathogenic |
— |
| RS2112040633 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS2112040676 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS2112040690 |
HCN1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS2112040707 |
HCN1
|
Health Risk |
Likely pathogenic |
— |
| RS2112040738 |
HCN1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 10 |
| RS2112054145 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112054380 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112054627 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112081965 |
MOCS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS2112084395 |
MOCS2
|
Health Risk |
Pathogenic |
— |
| RS2112090886 |
MOCS2
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS2112093130 |
CERT1
|
Health Risk |
Pathogenic |
— |